JCJacqueline Charles

Jacqueline Charles

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jacqueline Charles has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Culturally Tailored Materials for Smoking Cessation and HIV Care Adherence Among Hispanic Adults: Protocol for Content Development and Formative Evaluation (Preprint)

    by Lorra Garey, Jacqueline J Charles, Ashley L Ruiz, Rodrigo Castillo-Avilés, Virmarie Correa-Fernández, Marshall K Cheney, Thomas P Giordano, Michael J Zvolensky

    Hispanic people with HIV who smoke cigarettes experience unique stressors (eg, stigma), which contribute to health disparities. Anxiety sensitivity (AS) may worsen mood management problems, which are a leading barrier to smoking cessation. Interventions targeting AS can improve HIV-specific outcomes and smoking cessation. However, no prior research has culturally tailored an AS reduction program to improve quality of life among Hispanic people with HIV who smoke. The research team previously developed a mobile health (mHealth) intervention addressing AS reduction, smoking cessation, and HIV care management for Black people with HIV who smoke. Building on this work, this study represents a formative, exploratory phase to develop culturally tailored mHealth content for Hispanic people with HIV across 3 distinct regions (Mexico, Central America, and South America), which share many similarities but differ in some cultural and linguistic respects. This work will inform the refinement of materials for these groups and the future development of an integrated mHealth app for smoking, AS, and HIV among this population (ie, VITAL). This study aimed to culturally tailor evidence-based smoking cessation content targeting AS reduction and HIV management among Hispanic adults to inform the development of the VITAL mHealth program. Intervention content was culturally adapted using a theory-informed intervention adaptation framework that integrated a cultural considerations document derived from existing literature on smoking cessation and HIV care among the Hispanic population, along with iterative consultation with a Community Research Advisory Board. This resulted in linguistically tailored content in English and Spanish. The pilot study consisted of Hispanic people with HIV who smoke (N=80), divided into 3 subgroups: Mexican/Mexican American, Central American, and South American. Participants completed self-report assessments and a semistructured interview assessing the treatment videos for content relevance, appropriateness, and ease of understanding. Interviews were conducted online in Spanish or English by trained interviewers. Interview transcripts will be coded by a multidisciplinary qualitative team using a 2-pass approach: initial coding of the interview question followed by higher-level concepts. Themes will be reviewed by another member of the team to assess trustworthiness, saturation, and triangulated with quantitative data, then analyzed by geographic subgroup. Three linguistically tailored versions of the intervention materials were developed. Data collection began August 19, 2024, and finished June 26, 2025. Data cleaning is ongoing, and analyses will begin in April 2026. Content refinement and app integration are anticipated to be completed by September 2026. Upon completion of analysis, data will be used to further refine culturally tailored intervention content for Hispanic adult subgroups. This formative pilot study will inform the cultural adaptation and refinement of an mHealth app, VITAL, which will be tested in a subsequent randomized controlled trial to improve health disparities and assist Hispanic people with HIV in quitting smoking.

  • Open Access

    Culturally Tailored Materials for Smoking Cessation and HIV Care Adherence Among Hispanic Adults: Protocol for Content Development and Formative Evaluation (Preprint)

    by Lorra Garey, Jacqueline J Charles, Ashley L Ruiz, Rodrigo Castillo-Aviles, Virmarie Correa-Fernandez, Marshall K Cheney, Thomas P Giordano, Michael J Zvolensky

    BACKGROUND Hispanic adults living with HIV who smoke cigarettes experience unique stressors (e.g., discrimination and stigma), which increase their risk of developing health disparities. Among Hispanic adults, anxiety sensitivity (AS) may worsen mood management problems, which is a leading barrier to smoking cessation for this group. Interventions targeting AS can improve HIV-specific outcomes and smoking cessation. However, no work has culturally tailored an AS reduction program to improve the quality of life for Hispanic smokers living with HIV. OBJECTIVE This study aimed to adapt and refine culturally tailored intervention content targeting smoking cessation, AS reduction, and HIV management among Hispanic adults. METHODS Intervention content was developed and resulted in linguistically unique versions of the content in English and Spanish for Hispanic subgroups identifying as Mexican/Mexican American (M/MA), South American (SA), and Central American (CA) adults. This pilot study consisted of Hispanic adults (N=80), divided into three subgroups: M/MA, CA, and SA adults living with HIV who smoked. Study procedures included self-report assessments and a semi-structured interview involving the viewing of culturally tailored treatment videos to provide feedback on content relevance, appropriateness, and ease of understanding. RESULTS Upon completion of the study, qualitative and quantitative data collected will be used to further refine and adapt the intervention content for Hispanic adults (i.e., M/MA, CA, and SA). CONCLUSIONS Future work would integrate the refined culturally tailored content into the Vital app, which would be tested in a larger randomized controlled trial to improve health disparities and access to healthcare within the Hispanic community.

  • Open Access

    An Integrated mHealth App for Smoking Cessation in Black Smokers With HIV: Protocol for a Randomized Controlled Trial

    by Andre Bizier, Arielle Jones, Michael Businelle, Krista Kezbers, Bettina B Hoeppner, Thomas P Giordano, Jessica M Thai, Jacqueline Charles, Audrey Montgomery, Matthew W Gallagher, et al.

    Background: Black adults who smoke and have HIV experience immense stressors (eg, racial discrimination and HIV stigma) that impede smoking cessation success and perpetuate smoking-related health disparities. These stressors also place Black adults who smoke and have HIV at an increased risk of elevated interoceptive stress (eg, anxiety and uncomfortable bodily sensations) and smoking to manage symptoms. In turn, this population is more likely to smoke to manage interoceptive stress, which contributes to worse HIV-related outcomes in this group. However, no specialized treatment exists to address smoking cessation, interoceptive stress, and HIV management for Black smokers with HIV. Objective: This study aims to test a culturally adapted and novel mobile intervention that targets combustible cigarette smoking, HIV treatment engagement and adherence, and anxiety sensitivity (a proxy for difficulty and responsivity to interoceptive stress) among Black smokers with HIV (ie, Mobile Anxiety Sensitivity Program for Smoking and HIV [MASP+]). Various culturally tailored components of the app are being evaluated for their ability to help users quit smoking, manage physiological stress, and improve health care management. Methods: This study is a pilot randomized controlled trial in which Black combustible cigarette smokers with HIV (N=72) are being recruited and randomly assigned to use either (1) the National Cancer Institute’s QuitGuide app or (2) MASP+. Study procedures include a web-based prescreener; active intervention period for 6 weeks; smartphone-based assessments, including daily app-based ecological momentary assessments for 6 weeks (4 ecological momentary assessments each day); a video-based qualitative interview using Zoom Video Communications software at week 6 for participants in all study conditions; and smartphone-based follow-up assessments at 0, 1, 2 (quit date), 3, 4, 5, 6, and 28 weeks postbaseline (26 weeks postquitting date). Results: Primary outcomes include biochemically verified 7-day point prevalence of abstinence, HIV-related quality of life, use of antiretroviral therapy, and HIV care appointment adherence at 26 weeks postquitting date. Qualitative data are also being collected and assessed to obtain feedback that will guide further tailoring of app content and evaluation of efficacy. Conclusions: The results of this study will determine whether the MASP+ app serves as a successful aid for combustible cigarette smoking cessation, HIV treatment engagement, and physiological stress outcomes among Black people with HIV infection. If successful, this study will provide evidence for the efficacy of a new means of addressing major mental and physical health difficulties for this high-risk population. If the results are promising, the data from this study will be used to update and tailor the MASP+ app for testing in a fully powered randomized controlled trial that will evaluate its efficacy in real-world behavioral health and social service settings. Trial Registration: ClinicalTrials.gov NCT05709002; https://clinicaltrials.gov/study/NCT05709002 International Registered Report Identifier (IRRID): PRR1-10.2196/52090


  • Open Access

    An Integrated mHealth App for Smoking Cessation in Black Smokers With HIV: Protocol for a Randomized Controlled Trial (Preprint)

    by Andre Bizier, Arielle Jones, Michael Businelle, Krista Kezbers, Bettina B Hoeppner, Thomas P Giordano, Jessica M Thai, Jacqueline Charles, Audrey Montgomery, Matthew W Gallagher, et al.

    BACKGROUND Black adults who smoke and have HIV experience immense stressors (eg, racial discrimination and HIV stigma) that impede smoking cessation success and perpetuate smoking-related health disparities. These stressors also place Black adults who smoke and have HIV at an increased risk of elevated interoceptive stress (eg, anxiety and uncomfortable bodily sensations) and smoking to manage symptoms. In turn, this population is more likely to smoke to manage interoceptive stress, which contributes to worse HIV-related outcomes in this group. However, no specialized treatment exists to address smoking cessation, interoceptive stress, and HIV management for Black smokers with HIV. OBJECTIVE This study aims to test a culturally adapted and novel mobile intervention that targets combustible cigarette smoking, HIV treatment engagement and adherence, and anxiety sensitivity (a proxy for difficulty and responsivity to interoceptive stress) among Black smokers with HIV (ie, Mobile Anxiety Sensitivity Program for Smoking and HIV [MASP+]). Various culturally tailored components of the app are being evaluated for their ability to help users quit smoking, manage physiological stress, and improve health care management. METHODS This study is a pilot randomized controlled trial in which Black combustible cigarette smokers with HIV (N=72) are being recruited and randomly assigned to use either (1) the National Cancer Institute’s QuitGuide app or (2) MASP+. Study procedures include a web-based prescreener; active intervention period for 6 weeks; smartphone-based assessments, including daily app-based ecological momentary assessments for 6 weeks (4 ecological momentary assessments each day); a video-based qualitative interview using Zoom Video Communications software at week 6 for participants in all study conditions; and smartphone-based follow-up assessments at 0, 1, 2 (quit date), 3, 4, 5, 6, and 28 weeks postbaseline (26 weeks postquitting date). RESULTS Primary outcomes include biochemically verified 7-day point prevalence of abstinence, HIV-related quality of life, use of antiretroviral therapy, and HIV care appointment adherence at 26 weeks postquitting date. Qualitative data are also being collected and assessed to obtain feedback that will guide further tailoring of app content and evaluation of efficacy. CONCLUSIONS The results of this study will determine whether the MASP+ app serves as a successful aid for combustible cigarette smoking cessation, HIV treatment engagement, and physiological stress outcomes among Black people with HIV infection. If successful, this study will provide evidence for the efficacy of a new means of addressing major mental and physical health difficulties for this high-risk population. If the results are promising, the data from this study will be used to update and tailor the MASP+ app for testing in a fully powered randomized controlled trial that will evaluate its efficacy in real-world behavioral health and social service settings. CLINICALTRIAL ClinicalTrials.gov NCT05709002; https://clinicaltrials.gov/study/NCT05709002 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/52090